• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Industry

  • Print
  • Share
  • E-mail


Guidance documents represent FDA's current thinking on a topic.  They do not create or confer any rights for or on any person and do not operate to bind FDA or the public.  You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations.

Guidance documents describe FDA’s interpretation of our policy on a regulatory issue (21 CFR 10.115(b)). These documents usually discuss more specific products or issues that relate to the design, production, labeling, promotion, manufacturing, and testing of regulated products. Guidance documents may also relate to the processing, content, and evaluation or approval of submissions as well as to inspection and enforcement policies. 


How to Provide Input for Guidance Development 

Interested parties have a number of opportunities to provide input into guidance development.  For more information please see Opportunities for Input Into Guidance Development.(PDF) 21 KB
Interested parties also have a number of opportunities to comment on agency rulemaking.  For more information please see How to Comment on Proposed Regulations and Submit Petitions.


Possible Topics for Future Guidance Development


Guidance Documents By Product Area


Guidance Documents By Topic


Withdrawn Guidance Documents